Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Spotlight Correspondence
  • Published:

Histological features of acute hepatitis after imatinib mesylate treatment

Leukemia volume 17, pages 978–979 (2003)Cite this article

TO THE EDITOR

In a recent article in Leukemia, Ohyashiki et al1 reported the case of a chronic myeloid leukemia (CML) patient with imatinib-induced hepatotoxicity. Histological examination revealed lesions compatible with acute viral hepatitis. In the current report, we describe two other cases of serious imatinib-induced hepatotoxicity. Liver biopsies were performed in both patients and histology was compared with Ohyashiki's case.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ohyashiki K, Kuriyama Y, Nakajima A, Tauchi T, Ito Y, Miyazawa H et al. Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis. Leukemia 2002; 16: 2160–2161.

    Article  CAS  Google Scholar 

  2. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031–1037.

    Article  CAS  Google Scholar 

  3. Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001; 344: 1038–1042.

    Article  CAS  Google Scholar 

  4. Kantarjian H, Sawyers CL, Hochhaus A, Guilhot F, Schiffer C, Gambarcorti-Passerini C et al. for the International STI571 CML Study Group. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002; 346: 645–652.

    Article  CAS  Google Scholar 

  5. Talpaz M, Silver RT, Druker BJ, Goldman JM, Gambacorti-Passerini C, Guilhot F et al. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study. Blood 2002; 99: 1928–1937.

    Article  CAS  Google Scholar 

  6. Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG et al. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. Blood 2002; 99: 3530–3539.

    Article  CAS  Google Scholar 

  7. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347: 472–480.

    Article  CAS  Google Scholar 

  8. Periti P, Mazzei T, Mini E, Novelli A . Pharmacokinetic drug interactions of macrolides. Clin Pharmacokinet 1992; 23: 106–131.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France

    C James, G Marit, P Cony-Makhoul & F-X Mahon

  2. Laboratoire d'anatomopathologie Hôpital Haut-lévèque CHU, Bordeaux

    H Trouette

Authors
  1. C James
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Trouette
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Marit
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Cony-Makhoul
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F-X Mahon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

James, C., Trouette, H., Marit, G. et al. Histological features of acute hepatitis after imatinib mesylate treatment. Leukemia 17, 978–979 (2003). https://doi.org/10.1038/sj.leu.2402910

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402910

This article is cited by

Search

Advanced search

Quick links